Skip to main content
OpenTrials

Clinical trial condition

Urothelial Cancer

Explore clinical trials studying Urothelial Cancer. Study availability and eligibility vary by location and protocol.

56 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Cancer trial results

Recruiting

A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers

NCT07545122

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +16 more
Locations
  • Tasman Oncology Research Gold Coast, Queensland, Australia
  • Calvary Mater Hospital Newcastle Newcastle, Queensland, Australia
  • Linear Clinical Research Perth, Western Australia, Australia
View Trial Details
Recruiting

A Study to Survey Adults in South Korea With Cancer Who Receive PADCEV Injection

NCT06011954

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Site KR82001 Goyang-si, Gyeonggi-do, South Korea
  • Site KR82012 Suwon, Gyeonggi-do, South Korea
  • Site KR82008 Suwon, Gyeonggi-do, South Korea
  • Site KR82007 Jeollanam-do, South Korea
View all 18 locations
View Trial Details
Recruiting

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

NCT07421700

Conditions
Advanced/Metastatic Urothelial Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • UCLA Hematology/Oncology - Alhambra Alhambra, California, United States
View all 153 locations
View Trial Details
Recruiting

Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)

NCT07566156

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Samsun Clinic - Ridley-Tree Cancer Center Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Newark, Delaware, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details
Recruiting

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

NCT07227168

Conditions
Cervical Cancer, Colonic Diseases, Colorectal Cancer, +34 more
Locations
  • SCRI Denver Denver, Colorado, United States
  • SCRI FCS Sarasota Sarasota, Florida, United States
  • Mass General Cancer Center Boston, Massachusetts, United States
  • NEXT Austin Austin, Texas, United States
View Trial Details
Recruiting

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

NCT07193511

Conditions
Locally Advanced, Metastatic Solid Tumors, Neoplasm Metastasis, +6 more
Locations
  • Avenzo Therapeutics Recruiting Site San Francisco, California, United States
  • Avenzo Therapeutics Recruiting Site Aurora, Colorado, United States
  • Avenzo Therapeutics Recruiting Site Orlando, Florida, United States
  • Avenzo Therapeutics Recruiting Site Tampa, Florida, United States
View all 13 locations
View Trial Details
Recruiting

DK222 Study at Hopkins

NCT07140315

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +18 more
Locations
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Recruiting

Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy

NCT07106762

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0167 Gilbert, Arizona, United States
  • Local Institution - 0162 Fullerton, California, United States
  • Palo Alto Center-Palo Alto Medical Foundation Research Institute Palo Alto, California, United States
  • Sutter Health - Sutter Institute for Medical Research Sacramento, California, United States
View all 163 locations
View Trial Details

Related conditions